Introduction {#s1}
============

Autism spectrum disorder (ASD) is defined by dysfunction of social interaction and communication, stereotypic behavior and sensory integration problems. It is a complex neuro-developmental disease, which might result from an altered brain ontogenesis or altered neural homeostasis. According to the Centers for Disease Control and Prevention (CDC) the prevalence of ASD in the US population is 1∶88 [@pone.0095579-Centers1]. Until now, genetic explanations for ASD are limited to rare chromosomal abnormalities like copy number variations or very rare single gene disorders. A first hint to unravel pathophysiological pathway of ASD came from the identification of the mutation p.G406R found in the L-type calcium channel pore-forming subunit (Ca~V~1.2) gene *CACNA1C* in patients with Timothy Syndrome (TS) [@pone.0095579-Splawski1]. Whole-cell patch clamp recordings showed that the TS-mutation leads to a decelerated and incomplete inactivation of the calcium inward current. The phenotype of TS demonstrates the consequences of inadequate inactivation behavior of voltage gated calcium channels (VGCC) in different biological contexts, like heart, brain, and the immune system. Calcium channel inactivation is a key mechanism by which cells are able to tightly control intracellular calcium levels and therefore the activity of excitable cells. Of note, calcium channel inactivation is not exclusively controlled by the channel pore, but also depends on auxiliary subunits, namely Ca~V~β and Ca~V~α2δ [@pone.0095579-Birnbaumer1], [@pone.0095579-Takahashi1]. The assembly of the subunits and their specific isoforms determines the distinctive behavior of VGCCs for the neuronal function. The number of permutations of calcium channel complexes with their subunits, isoforms and splice-variants paves the way for fine-tuned calcium channel function adapted for information processing. There are transcripts of ten pore-forming Ca~V~α1-subunit genes (CACNA1A to CACNA1I and CACNA1S), which undergo extensive alternative splicing and in concert with auxiliary subunits exhibit different biophysical properties and expression profiles as well as distinct subcellular targeting [@pone.0095579-Ludwig1].

Particularly Ca~V~β-subunits have been shown to impact surface expression and modulation of channel activity and kinetics, leading to an increased L-type calcium channel activity, as revealed in whole-cell [@pone.0095579-Jangsangthong1], [@pone.0095579-Cens1] and single-channel recordings [@pone.0095579-Herzig1]. A wide variation of inactivation behavior has been described for the splice variants of the β2-subunit [@pone.0095579-Takahashi1]. Even slight structural differences within the Ca~V~β-subunit can strongly modify the gating behavior of L-type calcium channels [@pone.0095579-Herzig1]--[@pone.0095579-Buraei1]. Interestingly, the expression of distinct Ca~V~β-subunits within the brain is dependent on the stage of neuronal development [@pone.0095579-McEnery1]. Since the discovery of the TS-mutation and its effect on inactivation of the L-type calcium channel, additional calcium channel genes or loci have been associated with ASD, e.g. the genes for the pore-forming subunits *CACNA1D* [@pone.0095579-ORoak1], *CACNA1F* [@pone.0095579-HemaraWahanui1], *CACNA1G* [@pone.0095579-Strom1], *CACNA1H* [@pone.0095579-Splawski2] and the auxiliary subunit *CACNB1* [@pone.0095579-Strom1]. These studies emphasize the importance of calcium channel activity, inactivation and calcium signaling in a broader sense for the pathophysiology of ASD. Interestingly, the activity and kinetics of several pore-forming subunits of L-type (Ca~V~1.1--1.4) and Non-L-type (Ca~V~2.1--2.3) channels [@pone.0095579-Splawski1], [@pone.0095579-ORoak1], [@pone.0095579-HemaraWahanui1], [@pone.0095579-Limpitikul1] are regulated by Ca~V~β-subunits. Moreover, they are involved in various signaling pathways [@pone.0095579-Splawski1], [@pone.0095579-Splawski3], [@pone.0095579-Krey1], all of which have been linked to ASD pathophysiology previously. Nevertheless, studies considering the role of calcium channels in ASD have focused on the pore-forming subunits of the calcium channel complex, even though gene clusters of interacting proteins participating in linear signaling pathways would have a similar chance of being involved in the etiology of ASD [@pone.0095579-Iossifov1].

Based on our previous studies showing that current and gating kinetics profoundly depend on the particular Ca~V~β-subunit isoform or splice variant associated with the channel pore [@pone.0095579-Herzig1], [@pone.0095579-Jangsangthong2], we hypothesized that Ca~V~β-subunit mutations might lead to electrophysiological phenotypes similar to that observed in TS. Though all four Ca~V~β-subunit genes (*CACNB1*--*CACNB4*) are expressed within the brain [@pone.0095579-Volsen1] we chose *CACNB2* because of positional evidence from a meta-analysis of linkage data [@pone.0095579-Trikalinos1]. Here, Trikalinos and colleagues showed genome-wide suggestive significance for a designated bin 10p12--q11.1, which embraces a large genomic region including the *CACNB2* gene in autistic siblings. Recently, *CACNB2* was found as a risk locus for five major psychiatric disorders including ASD [@pone.0095579-CrossDisorder1] and thus is regarded as a susceptibility gene.

In our current study, we searched for mutations in the β2-subunit gene that might affect gating behavior of voltage-dependent calcium channels. In a mutation screening, 155 patients with ASD were sequenced and the results were filtered for most promising candidates. We included only missense variants, which were not present in our cohort of 259 matched controls and located in highly conserved regions of the protein as an indicator of functional importance. Furthermore, the mutations had to be unknown or potentially damaging according to in-silico predictions.

Here, for the first time, we present three missense mutations located in conserved regions of the calcium channel *CACNB2* gene found in three families affected by ASD. In electrophysiological analyses of recombinant channels, these missense mutations were found to differentially alter current kinetics. Though our data do not prove an association between these *CACNB2* mutations and ASD, our findings support the idea of Cavβ2 variants being of functional relevance for ASD pathophysiology.

Materials and Methods {#s2}
=====================

Ethics Statement {#s2a}
----------------

Procedures were approved by the Institutional Review Board (application number 04-223) of the medical faculty of the University of Cologne.

Subjects {#s2b}
--------

gDNA samples were available from 259 healthy controls and 155 patients with Autistic Spectrum Disorder (ASD), each are ethnically matched groups of Caucasians of west-European origin. The cases were elicited from three different sources: Twenty patients were recruited by the Department of Child & Adolescent Psychiatry and Psychotherapy, University of Cologne. These patients meet diagnostic criteria for 'broad ASD' (e.g. Aspergers's) based on interview for DSM-IV-R. A written informed consent was obtained from the parents or legal guardians of the minors using the consent form approved by the I.R.B. of the University of Cologne (Germany). Ten cases were included from Autism Tissue Program (www. atpportal.org) from the Maryland National Institute of Child Health and Human Development (NICHD) Brain Tissue Center and the Harvard Brain Tissue Resource Center (USA), published e.g. in [@pone.0095579-Lintas1]. 125 cases were provided by the Autism Genetic Resource Exchange (AGRE) Consortium (<http://research.agre.org/program/descr.cfm>). All AGRE-Patients met diagnosis for 'autism' and each family was ascertained on the condition that at least two individuals were diagnosed with ASD [@pone.0095579-Geschwind1], where diagnostic tests included autism diagnostic interview-revised (ADI-R) [@pone.0095579-Lord1] and the autism diagnostic observational schedule (ADOS) [@pone.0095579-Lord2]. Regulatory review, approval, and oversight of AGRE's human subject research is provided by Western IRB (title: AUTISM GENETIC RESOURCE EXCHANGE). In order to find new sequence variations with a putative function-altering effect, all exons and their flanking intronic sequences of *CACNB2* were sequenced in 155 ASD patients. The number of sequenced cases enabled the detection of rare SNPs (f = 0.01) with a probability of 96% to detect it once and 81% to detect it twice. The power calculation was made according to Glatt et al. [@pone.0095579-Glatt1]. To assure a strong genetic background, patients from multiplex families with a severe phenotype were selected.

The control group consisting of 259 matching controls was kindly provided by Dr. Heusch and Dr. Brodde, published in [@pone.0095579-Leineweber1]. Based on the gender-dependent frequency of ASD [@pone.0095579-Centers1], we chose an appropriate male to female ratio for both groups of about 5∶1.

Genotypic and DNA Sequence Analyses {#s2c}
-----------------------------------

Oligonucleotides to all known exons of the *CACNB2* gene were designed according to genomic sequences found in the Celera data base using Primer3. PCR amplification of DNA samples was carried out with GoTaq (Promega) according to the manufacturer's protocol; annealing temperature was chosen according to Primer3. Mutational analyses were carried out with Mutation Surveyor. PCR fragments were purified using ExoI and SAP (NEB), and sequencing was performed with an ABI 3730 automated DNA sequencer.

DNA Constructs and Site-directed Mutagenesis {#s2d}
--------------------------------------------

For functional analysis, mutations p.G167S and p.S197F were introduced in human β~2d~cDNA (NM_201596.2) and the mutation p.F240L was introduced in β~2d_E7c~ (NM_201597.2) by site-directed mutagenesis (Stratagene QuikChange Kit) and verified by sequencing.

EGFP was used as reporter gene, which was coexpressed together with the β2-subunit by the bicistronic pIRES2-EGFP vector (Clontech). G167S forward primer 5′-gatagggcgattggtaaaagaaagctgtgaaatcggattc-3′; G167S reverse primer 5′-gaatccgatttcacagctttcttttaccaatcgccctatc-3′; S197F forward primer 5′-cagagagccaagcaagggaaattctacttcagtaaatcaggaggaaattcatcatcc-3′; S197F reverse primer 5′-ggatgatgaatttcctcctgatttactgaagtagaatttcccttgcttggctctctg-3′; F240L forward primer 5′-ggaaaactgcaggcttgctttggcggtttactaca; F240L reverse primer 5′-tgtagtaaaccgccaaagcaagcctgcagttttcc.

Cell Culture {#s2e}
------------

In brief, HEK-293α1c cells stably expressing Ca~v~1.2 subunit (GeneBank accession \#NM_000719) cloned from human heart [@pone.0095579-Schultz1] were grown in Petri dishes in Dulbeccos modified Eagle medium (PAA, Germany) supplemented with 10% FBS (PAA, Germany), penicillin (10 U/ml), and streptomycin (10 µg/ml; PAA, Germany). Cells were selected by geneticin (G418) (PAA, Germany) at a final concentration of 500 µg/ml. Cells were routinely passaged twice a week and incubated at 37°C under 6% CO~2~ growth conditions. HEK-293 α1c cells were transfected using SuperFect reagent (Qiagen). For whole-cell recordings, cells were transfected with a 2∶3 ratio of either human WT or mutant β~2d~-subunit and human α~2~δ~1~-subunit [@pone.0095579-Schleithoff1].

Electrophysiology {#s2f}
-----------------

Whole-cell recordings in EGFP-positive cells were obtained 48--72 h after transfection. Immediately prior to recording, cells kept in 35-mm culture dishes were washed at room temperature (19--23°C) with bath solution. For constructs based on human β~2d~cDNA (NM_201596.2) the bath solution contained (in mM) 20 BaCl~2~, 1 MgCl~2~, 10 HEPES, 40 TEA-Cl, 10 dextrose, and 65 CsCl (pH 7.2 with TEA-OH) and pipette solution (in mM) 105 CsCl, 25 TEA-Cl, 11 EGTA, and 10 HEPES (pH 7.2 with CsOH). Holding potential was −100 mV. For constructs based on human β2d_E7c cDNA (NM_201597.2) the bath solution contained (in mM) 5 BaCl~2~, 1 MgCl~2~, 10 HEPES, 40 TEA-Cl, 10 dextrose, and 92 CsCl (pH 7.2 with TEA-OH). Patch pipettes made from borosilicate glass (1.7 mm diameter and 0.283 mm wall thickness, Hilgenberg GmbH, Malsfeld, Germany) were pulled using a Sutter Instrument P-97 horizontal puller and fire-polished using a Narishige MF-83 microforge (Narishige Scientific Instrument Lab, Tokyo, Japan). Pipette resistance was 2--4 MΩ.

Currents were elicited by applying test potentials of −40 mV to +60 mV from a holding potential of −100 mV using Clampex software pClamp 5.5 and an Axopatch 1D amplifier (Axon Instruments, Foster City, CA, USA). Voltage dependence of Ba^2+^ current inactivation in HEK cells was determined with a two-pulse protocol. For β~2d~cDNA (NM_201596.2) constructs the conditioning first pulse (stepped from −100 mV to +40mV) was held for 5s and the second pulse (of +10mV) for 125 ms; for β~2d_E7c~cDNA (NM_201597.2) constructs the conditioning pulse was stepped from −75 mV to +5 mV for 1 s and the second pulse (of +10 mV) was held for 125 ms. For both steady-state inactivation protocols the relative magnitude of inward current elicited during the second pulse was plotted as a function of the voltage of the conditioning first pulse.

Data were analyzed using pCLAMP6 (Axon Instruments) and GraphPad 5 Prism. Currents were filtered at 2 kHz. Data were fitted to a Boltzmann function to obtain the half point (V0.5) and slope factor (dV) for the voltage dependence of inactivation; Fits were performed after subtracting the offset from the peak values of the steady-state inactivation data. Offset was defined as a deviation from zero at the end of a fully inactivating current (after a 5000ms prepulse followed by a 125ms test pulse at +10mV). For voltage dependence of activation data were fitted by combined Ohm and Boltzmann relation according to [@pone.0095579-Karmazinova1].

Statistical Analysis {#s2g}
--------------------

Student's unpaired two-tailed t-test (GraphPad Prism 5, GraphPad Software, San Diego, CA) was used to compare electrophysiological parameters gained with the several CACNB2 mutations and their corresponding wildtypes. P\<0.05 was considered significant. All p-values are listed in [table S2](#pone.0095579.s002){ref-type="supplementary-material"}. Data are presented as mean ± SEM.

Results {#s3}
=======

We performed a screening for mutations in *CACNB2* by sequencing all 19 exons and their flanking intronic regions from 155 patients with ASD. All variants found are listed in [table S1](#pone.0095579.s001){ref-type="supplementary-material"}. We filtered for variants causing non-synonymous substitutions, frameshifts, or splice site changes and identified six missense mutations. Since two of them occurred at similar frequencies in our patient cohort, our control cohort, and the NCBI database of short genetic variations (dbSNP), they were not further considered. One substitution ("New11" in [tabl S1](#pone.0095579.s001){ref-type="supplementary-material"}.) is likely to be benign according to the prediction of polymorphism phenotyping tool (PolyPhen2); also the amino acid exchange of the minor allele is prevalent in other species (data not shown). Three non-synonymous mutations were located in conserved domains of the protein ([Fig. 1](#pone-0095579-g001){ref-type="fig"}) and subsequently analyzed for functional effects. They were detected in three different patients who all were heterozygous carriers ([Fig. 2a](#pone-0095579-g002){ref-type="fig"}). The mutations were absent from 259 healthy controls.

![Splice scheme of human *CACNB2* resulting in 9 splice variants of the Ca~V~β2-subunit with the localization of the three mutations.\
Spliced exons are shown in light grey and conserved exons in dark grey. All nine splice variants express the mutation-carrying exon 5, while three of variants contain the localization of the third mutation in exon 7c [@pone.0095579-Buraei1].](pone.0095579.g001){#pone-0095579-g001}

![(**a**) Chromatogram showing point mutations for patient 1--3. (**b**) The pedigrees show the occurrence of the disease phenotype and the inheritance of missense mutations in *CACNB2*. *Circles* and *squares* indicate females and males, respectively. *Filled* symbols denote diagnosis of autism; *partially filled* symbols denote individuals that are diagnosed within a broad spectrum of pervasive developmental disorders. (**c**) Alignments show conservation among different species for p.G167S, p.S197F and p.F240L suggesting an importance for the topology and function.](pone.0095579.g002){#pone-0095579-g002}

Patient 1 showed a variation at cDNA position 334 from guanine to adenine resulting in an amino acid exchange from glycine to serine (p.G167S, referring to NM_201596.2). The substitution is not annotated in dbSNP and according to the PolyPhen2 prediction 'probably damaging' for the Ca~V~β2 function. Patient 2 had the cytosine at position 425 changed to thymine resulting in a substitution of phenylalanine for serine (p.S197F). This mutation is an annotated rare variant and shows a 'possibly damaging' PolyPhen2 score. The third affected patient had the transition c.T553C which results in a phenylalanine-to-leucine change (p.F240L, referring to NM_201597.2). The missense mutation is not annotated and PolyPhen2 predicts a 'benign' phenotyping score. The mutations p.G167S and p.S197F were found by analyzing the fifth exon, which is expressed in all splice isoforms; p.F240L was found in the alternative exon 7c (nomenclature according to Foell et al. [@pone.0095579-Foell1]). All patients were diagnosed with autism by both ADI-R and ADOS. The clinical features of the patients are compiled in [table 1](#pone-0095579-t001){ref-type="table"}.

10.1371/journal.pone.0095579.t001

###### Clinical Features of ASD patients with rare mutations in *CACNB2*.

![](pone.0095579.t001){#pone-0095579-t001-1}

  Description              Patient 1       Patient 2     Patient 3
  -------------------- ----------------- ------------- -------------
  **Mutations**           *c.334G\>A*     *c.425C\>T*   *c.553T\>C*
  *(\# NM_201597.2)*       *p.G167S*       *p.S197F*     *p.F240L*
  **Genotype**               *+--*           *+--*         *+--*
  **Gender**                   M               M             F
  **Epilepsy**                Yes           Unknown         No
  Type                  Complex partial       --            --
  **Autism**                                           
  ADI-R                     Autism          Autism        Autism
  ADOS                      Autism          Autism        Autism
  **Brain Imaging**                                    
  MRI                       normal          Unknown       Normal

**ADI-R**, Autism Diagnostic Interview-Revised; **ADOS**, Diagnostic Observation Schedule-Generic; **MRI,** magnetic resonance imaging.

The subsequently performed cosegregation analysis showed a low penetrance. Two variants showed incomplete segregation since some siblings, who were not obviously affected, were carriers of the mutation ([Fig. 2b](#pone-0095579-g002){ref-type="fig"}). Since complex-genetic disorders manifest depending on multiple factors, a low penetrance and incomplete cosegregation can be expected. In the literature, it has been suggested that pathogenic variants might be masked by epigenetic marks and thus are less penetrant [@pone.0095579-Feinberg1] or that pathogenic variants follow an oligogenic pattern of inheritance, resulting in more severe or different phenotypes or are modified by the presence of additional variants [@pone.0095579-Mitchell1]. Accordingly, unaffected carriers of a mutation might be possibly influenced by unknown genetic and epigenetic mechanisms [@pone.0095579-Geschwind2] or might be subclinically affected.

As members of the membrane-associated guanylate kinase (MAGUK) protein family [@pone.0095579-Herzig1]--[@pone.0095579-Buraei1], β-subunits are comprised of two highly conserved central (GK and SH3) domains, flanked and interspersed by more variable N- and C-termini and a central HOOK domain ([Fig. 1](#pone-0095579-g001){ref-type="fig"}). The β2-subunit is subject to extensive alternative splicing of the N-terminus and within the central HOOK domain, comprising the alternative exons 7a-c ([Fig. 1](#pone-0095579-g001){ref-type="fig"}) [@pone.0095579-Colecraft1]. All three mutations are located within the HOOK domain ([Fig. 1](#pone-0095579-g001){ref-type="fig"}), which is known to modulate calcium channel inactivation [@pone.0095579-MirandaLaferte1], [@pone.0095579-He1]. The wildtype sequence of all three missense mutations revealed full conservation across species ([Fig. 2c](#pone-0095579-g002){ref-type="fig"}) indicating functional relevance.

To investigate the effect of the mutations on calcium channel function, we heterologously expressed WT and mutant forms of the human β2 together with human α2δ1 and EGFP in HEK-293 cells stably expressing a human Ca~V~1.2 pore-forming subunit, followed by whole-cell patch-clamp recordings. There are nine splice-variants of Ca~V~β2, with different inactivation kinetics [@pone.0095579-Takahashi1]. The mutations p.G167S and p.S197F are present in all these Ca~V~β2 splice forms, and there is no predominant splice form in the brain. In accordance with our hypothesis and deductions from the TS-channel model, we expect a reduction of the channels inactivation rate. To evaluate this effect in the mutations we performed whole-cell experiments using Ba^2+^ as charge carrier, since the TS-mutation selectively decelerates time-dependent inactivation and spares or even accelerates calcium-dependent inactivation [@pone.0095579-Barrett1]. For the quantification of mutants' influence on channel inactivation behavior we chose the β2d splice variant as a suitable reference isoform, because of its relatively fast inactivation kinetics [@pone.0095579-Takahashi1], [@pone.0095579-Herzig1]. We compared the WT with the mutations p.G167S and p.S197F and the mutation p.F240L was analyzed separately with an appropriate WTE7c including its alternative exon 7c. The respective splice forms β2d (NM_201596.2) and β2dE7c (NM_201597.2) are -- according to the GNF Expression Atlas 1 and 2 - expressed in fetal brain and in various adult brain regions.

Peak current densities tended to be enhanced in the mutants β2d_G167S and β2d_S197F compared to β2d_WT. These mutations also caused a slight, non-significant shift of the I-V relationships towards more positive test potentials ([Fig. 3a](#pone-0095579-g003){ref-type="fig"}). Conversely, for the mutation of the β2dE7c_WT (β2dE7c_F240L), the I-V relationship revealed a trend towards enhanced channel activity at negative test potentials ([Fig. 3b](#pone-0095579-g003){ref-type="fig"}).

![I--V relationships.\
Currents were elicited from −40 to +60 mV in 10 mV increments with 5 mM or 20 mM Ba^2+^, respectively. The holding potential was −100 mV. Current density of the variants p.G167S (N = 11) and p.S197F (N = 8) in (**a**) and p.F240L (N = 5) in (**b**) were compared with their respective WTs (β2d_WT: N = 9 and β2dE7c_WT: N = 5).](pone.0095579.g003){#pone-0095579-g003}

Steady-state inactivation was examined using two-pulse protocols. Data and Boltzmann fits are depicted in [Fig. 4a and 4b](#pone-0095579-g004){ref-type="fig"}. The voltage of half-maximal inactivation (V0.5~inact~) did not differ significantly between the three mutant channel complexes and their respective controls ([Fig. 4c](#pone-0095579-g004){ref-type="fig"}). However, a significant flattening of the Boltzmann curves was observed for β2d_G167S and β2d_S197F, as indicated by the slope factor dV ([Fig. 4d](#pone-0095579-g004){ref-type="fig"}). Numeric values are compiled in [table 2](#pone-0095579-t002){ref-type="table"}.

![Voltage-dependent steady-state inactivation (a, b) of Ba^2+^ currents through L-type calcium channels.\
The ASD mutants p.G167S (N = 4) and p.S197F (N = 6) showed a significantly flattened slope of voltage-dependent inactivation compared to β2d_WT (N = 7). The third mutation β2dE7c_F240L. (N = 5) did not obviously differ from its corresponding β2dE7c_WT (N = 2). Half-inactivation potentials (V0.5~inact~) (**c**) and the slope factors dV (**d**) were obtained from the fits of individual experiments using the Boltzmann equation and averaging the results. Asterisk (\*) marks a statistical significance (P\<0.05) compared to the respective WT.](pone.0095579.g004){#pone-0095579-g004}

10.1371/journal.pone.0095579.t002

###### Current and voltage parameters (mean ± SEM) of the constructs tested.

![](pone.0095579.t002){#pone-0095579-t002-2}

                                    −β2d    β2d_WT                   β2d_G167S                                β2d_S197F                  β2dE7c_WT   β2dE7c_F240L
  -------------------------------- ------ ----------- ---------------------------------------- ---------------------------------------- ----------- --------------
  Peak Current Density \[pA/pF\]    −1.2     −56.5                     −72.3                                    −68.8                      −17.8        −21.1
                                    ±1.0     ±8.6                      ±10.3                                     ±9.7                      ±5.8          ±3.6
  V0.5~act~ \[mV\]                   --      −11.9                      −9.8                                     −6.3                      −13.6        −18.7
                                             ±2.0                       ±1.2                                     ±2.5                      ±0.36         ±2.5
  **Steady-state Inactivation**            **N = 7**                 **N = 4**                                **N = 6**                  **N = 2**    **N = 5**
  V0.5~inact~ \[mV\]                         −38.7                     −47.9                                    −35.7                      −33.3        −28.2
                                             ±1.8                       ±5.6                                     ±3.7                      ±0.7          ±1.9
  dV                                          9.7      16.9 [\*](#nt103){ref-type="table-fn"}   13.5 [\*](#nt103){ref-type="table-fn"}      8.1          8.8
                                             ±1.2                       ±2.9                                     ±1.0                      ±1.5          ±0.7

**V0.5~act~,** Voltage of half-maximal activation; **V0.5~inact~,** half-maximal inactivation voltage, dV, slope factor; −**β2d,** mock transfected cells;

\*indicates P\<0.05 versus corresponding WT.

As described previously for the Timothy Syndrome, the most notable differences between mutants and WT were observed in the time course of whole-cell Ba^2+^ currents. The mutant β2d_G167S and β2d_S1967F subunit induced a decelerated time-dependent inactivation of the channel complex within a 150ms test pulse ([Fig. 5a](#pone-0095579-g005){ref-type="fig"}). The WT with the alternative exon 7c inactivated more slowly than the WT with exon 7a. It was therefore examined using an extended test pulse duration (see scale bars in [Fig. 5a](#pone-0095579-g005){ref-type="fig"}). Compared with the adequate β2dE7c_WT the mutant β2dE7c_F240L showed an accelerated time-dependent inactivation. The mutants and the WT with Exon 7a were recorded with 20mM Ba^2+^ (compare [@pone.0095579-Jangsangthong2]) and those with exon 7c were recorded with 5mM Ba^2+^ because of insufficient voltage-control with 20 mM Ba^2+^ and prolonged test pulse protocols (500ms). We analyzed the extent of time-dependent inactivation as the percentage of current that has inactivated after 150ms of depolarization (% inactivation). As expected from the representative whole-cell current traces, the currents inactivated significantly more slowly for all test potentials in case of β2d_S197F and at −20mV in case of β2d_G167S ([Fig. 5b](#pone-0095579-g005){ref-type="fig"}). In contrast, the mutant β2d_F240L led to faster, more pronounced inactivation compared to its corresponding WT ([Fig. 5c](#pone-0095579-g005){ref-type="fig"}). After 1000ms the currents of β2d_WT, β2d_G167S and β2d_S197F showed a comparable extent of inactivation of 94±1%, 99±2% and 96±3% at 0mV test potential.

![Time-dependent inactivation.\
Representative whole-cell Ba^2+^ current traces (a) of Ca~V~1.2/α2δ1 co-expressed with β2d_WT -subunit or co-expressed with the ASD mutants β2d_G167S, β2d_S197F or the β2dE7c_WT or its variant β2dE7c_F240L. The currents were elicited from a holding potential of −100 mV by 150 ms (or 500ms) step depolarization of −40 to +50 mV with 20 mM Ba^2+^ (for β2d variants) or 5 mM Ba^2+^ (for β2dE7c variants), respectively. Analysis of the extent of time-dependent inactivation. (**b**, **c**) % Inactivation was analyzed as the remaining fraction of whole-cell current that has not inactivated after 150 ms of depolarization. β2d_WT (N = 12), β2d_G167S (N = 8), β2d_S197F (N = 11) (**c**) Similar analysis for β2dE7c variants β2dE7c_WT (N = 5), β2dE7c_F240L (N = 6). Asterisk (\*) marks a statistical significance (P\<0.05) compared to the respective WT, (\*\*) marks P\<0.01.](pone.0095579.g005){#pone-0095579-g005}

Discussion {#s4}
==========

The complex genetic principle of origin underlying ASD is still to be elucidated [@pone.0095579-Geschwind3]. So far, genome-wide association and linkage studies presented inconsistent loci, reflecting a broad etiological heterogeneity and suggesting the influence of rare variants weighted by common susceptibility alleles. To put the spectrum and the genes into a pathophysiological context, an oligogenic model with epistasis has been assumed [@pone.0095579-Folstein1], [@pone.0095579-Leblond1]. It describes - based on their level of biological function - a combination of multiple interacting genes resulting in ASD phenotypes.

Until now, few potential pathophysiological mechanisms have been postulated [@pone.0095579-Abrahams1], [@pone.0095579-BenDavid1]. The role of impaired calcium channel inactivation for ASD was revealed by Splawski and colleagues with the TS-mutation (*CACNA1C*: p.G406R) [@pone.0095579-Splawski1]. In more general terms, calcium signaling was found by a gene pathway analysis based on the 'Kyoto Encyclopedia of Genes and Genomes' (KEGG) as one of the three most significant pathways for ASD [@pone.0095579-Skafidas1]. The concept is further supported by the association of mutations in various calcium channel genes with non-idiopathic ASD [@pone.0095579-Splawski1], [@pone.0095579-HemaraWahanui1]--[@pone.0095579-Limpitikul1]. The activity and regulation of all L-type and some non-L-type calcium channels are dependent on their auxiliary β-subunit; therefore, the highly differentiated β-subunit function is expected to be crucial for proper function of the calcium channel complex and homeostasis in the nervous system.

Here, we present for the first time rare substitutions in highly conserved residues of the calcium channel subunit β2 in three out of 155 individuals with ASD, all of which were absent from 259 matching controls. According to the exome variant server (<http://evs.gs.washington.edu/EVS>), 100 variations (35 of which are missense, splice or frame-shift mutations) are known for European Americans in *CACNCB2*. Thus, a statistical proof of an elevated frequency of rare variants in the *CACNB2* gene in ASD patients was considered not feasible. We did not test for differences in the mutation frequency between ASD patients and controls. Instead, we searched for most promising candidates of putative causal variants. Subsequently, by using patch clamp, the variants were tested for putative impairment of the function of the channel complex. Electrophysiological analyses in HEK-cells by whole-cell patch-clamp recordings demonstrate that all three missense mutations significantly alter the kinetics of the currents carried by the Ca~V~1.2 complex. Two mutations in the Ca~V~β2-subunit lead to deceleration of time-dependent inactivation of Ba^2+^ currents as well as altered sensitivity of voltage-dependent inactivation. The third mutation shows a non-significant hyperpolarizing shift in current-voltage relation and an accelerated time-dependent inactivation. Of note decelerated time-dependent inactivation and incomplete voltage-dependent inactivation behavior are the biophysical hallmarks of the TS-mutation p.G406R in *CACNA1C* [@pone.0095579-Splawski1], [@pone.0095579-Splawski3], [@pone.0095579-Barrett1].

We observed a low penetrance of the three mutations in the ASD families under investigation, indicating the influence of other factors on the full expression of the condition. However, rare variants might contribute to the complex genetics and clinical heterogeneity of ASD. For comparison, an analogous sequencing approach studying *CACNA1H* as a candidate gene for ASD in 461 patients revealed six non-synonymous mutations in conserved domains, all showing a low penetrance and incomplete segregation [@pone.0095579-Splawski2]. Expression of complex genetic disorders depends on multiple factors, therefore a low penetrance of causal variants is quite common. Unaffected carriers might be subclinically affected, other risk factors might have contributed to the phenotype in the affected individuals, or the described mutations may only act as modifiers of the phenotype. Even for the Timothy syndrome - one of the most penetrant monogenic forms of autism - ASD has a penetrance of ∼75% only [@pone.0095579-Bader1].

The putative effects of the Ca~V~β2-mutations are ample as the β-subunit also plays an essential role as an interaction partner with intracellular signaling machineries. For instance, Krey et al. have recently demonstrated a new pathway involving the TS-mutation which leads to a calcium channel activity-dependent and conformation-dependent dendrite retraction via Gem-induced RhoA-signaling [@pone.0095579-Krey1]. Here, the Ca~V~β-subunits might be involved in two ways: firstly they are known to regulate the channel activity, but secondly the interaction of Ca~V~1.2 with Gem, mediated through the β-subunit is important for the ability of the channel to control activity-dependent dendritic arborization [@pone.0095579-Krey1]. In summary, the role of the Ca~V~β2-subunit as a risk factor for ASD can not only be attributed to its interaction with diverse ASD-associated pore-forming Ca~V~α1-subunits, but also because the Ca~V~β2-subunit acts as a signaling hub and can link together different ASD pathways.

The mutations presented here appear to follow a similar but milder mechanism of action that occurs in TS. TS presents with a multi-organ dysfunction, possibly indicating the consequences of a dramatic elevation of the intracellular calcium concentration. Mutations resulting in an even larger effect would likely abort the organism's development [@pone.0095579-Liao1]. Thus the mutation of the TS can be viewed as an extreme of the viable spectrum of mutations within the calcium signaling pathway. Compared to this, the mutations β2d_G167S, β2d_S197F and β2d_F240L exhibited rather moderate effects on channel gating that nonetheless might suffice to unbalance neuronal calcium channel function.

Because private and rare mutations seem to play a role in the predisposition to ASD [@pone.0095579-BenDavid1], the discovery of rare variants with putative functional relevance might contribute to our understanding of the disorder's etiology. Integrating the data from TS [@pone.0095579-Splawski1], the meta-analysis of psychiatric disorders [@pone.0095579-CrossDisorder1], and functional studies on auxiliary β-subunits, we propose that inappropriate function of different components of the voltage-gated calcium channel complex can result in or may contribute to autism spectrum disorder. More detailed biophysical and cell-biological studies under physiological conditions are warranted for all such mutations.
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